(E)-N1-(2-(4-chlorostyryl)benzo[g]quinazolin-4-yl)-N3,N3-dimethylpropane-1,3-diamine

ID: ALA3425697

PubChem CID: 118736571

Max Phase: Preclinical

Molecular Formula: C25H25ClN4

Molecular Weight: 416.96

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CN(C)CCCNc1nc(/C=C/c2ccc(Cl)cc2)nc2cc3ccccc3cc12

Standard InChI:  InChI=1S/C25H25ClN4/c1-30(2)15-5-14-27-25-22-16-19-6-3-4-7-20(19)17-23(22)28-24(29-25)13-10-18-8-11-21(26)12-9-18/h3-4,6-13,16-17H,5,14-15H2,1-2H3,(H,27,28,29)/b13-10+

Standard InChI Key:  ARMHCDAHKQVAOY-JLHYYAGUSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -2.6009   -3.0010    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5978    1.5002    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8968    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8968   -0.7501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5978   -1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2989   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2989    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1981    1.4978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4967    0.7456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7980    1.4933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0971    0.7433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3962    1.4933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3962    2.9933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0972    3.7433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7981    2.9934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.4355    3.5933    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -3.9017   -3.7496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9048   -5.2504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2806    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2806   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5978   -1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8968   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8968    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5978    1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2057   -5.9989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2087   -7.4998    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2488   -8.0983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1706   -8.1016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7 22  2  0
 21  8  2  0
  8  9  1  0
  2  9  2  0
  6  9  1  0
  1  5  1  0
  3 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
  1 19  1  0
 19 20  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 20 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3425697

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 416.96

Molecular Weight (Monoisotopic): 416.1768

AlogP: 5.97

#Rotatable Bonds: 7

Polar Surface Area: 41.05

Molecular Species: BASE

HBA: 4

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 9.40

CX LogP: 6.37

CX LogD: 4.37

Aromatic Rings: 4

Heavy Atoms: 30

QED Weighted: 0.30

Np Likeness Score: -0.94

References

1. Nepomuceno GM, Chan KM, Huynh V, Martin KS, Moore JT, O'Brien TE, Pollo LA, Sarabia FJ, Tadeus C, Yao Z, Anderson DE, Ames JB, Shaw JT..  (2015)  Synthesis and Evaluation of Quinazolines as Inhibitors of the Bacterial Cell Division Protein FtsZ.,  6  (3): [PMID:25815151] [10.1021/ml500497s]

2. Baska F, Sipos A, Őrfi Z, Nemes Z, Dobos J, Szántai-Kis C, Szabó E, Szénási G, Dézsi L, Hamar P, Cserepes MT, Tóvári J, Garamvölgyi R, Krekó M, Őrfi L..  (2019)  Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases.,  184  [PMID:31614258] [10.1016/j.ejmech.2019.111710]

Source

Source(1):

• Scientific Literature